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changes in intrathoracic pressure. Leftward shift of the ventricular
septum during inspiration though may impair filling of the LV
and, consequently, diminish Vp.
Finally, we would like to solicit the authors’ comments, and we
wonder whether a respiratory variation in Vp may be a marker for
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REPLY
The recent implementation of new Doppler echocardiographic
methods for the assessment of diastolic function has improved our
understanding of this complex entity. Standard indices of trans-
mitral flow are hampered by their dependency on loading condi-
tions and left ventricular (LV) relaxation and have therefore been
unable to differentiate a patient with normal (normal relaxation
and preload) versus pseudonormal (impaired relaxation and in-
creased preload) LV filling (1). More recently, the velocity of flow
propagation into the LV (Vp) has been shown to provide an
estimate of LV relaxation (2,3). Takatsuji et al. (4) studied a large
group of patients with normal relaxation, delayed relaxation and
pseudonormal pulsed Doppler patterns of LV filling confirmed by
hemodynamic findings. While pulsed Doppler indices showed the
typical “U-shaped” distribution from normal to delayed relaxation
in pseudonormal patients, color M-mode Doppler Vp was equally
low between the last two groups. Furthermore, their study also
showed a strong negative correlation between t and Vp, despite a
wide variability in LV filling pressures among the three groups of
patients, suggesting that Vp was less influenced by preload. In a
study published in the January 2000 issue of the Journal (5), we
demonstrated in controlled experimental settings that Vp was not
affected by preload reductions in dogs undergoing caval occlusion
and humans during partial bypass.
The letter of Togni et al., describing the changes in color
M-mode flow propagation velocity (Vp observed in a patient with
cardiac tamponade, is of significant interest. The authors demon-
strate 1) significant respiratory variability of Vp during cardiac
tamponade, increasing during inspiration and 2) a significant
decrease in Vp after pericardiocentesis. A possible explanation for
the respiratory variability observed may be periodic misalignment
between the direction of flow and the M-mode cursor, changing
the Doppler angle of incidence. This is likely to occur in the
presence of a large pericardial effusion, when increased inspiratory
venous return to the right heart can result in lateral translation of
the LV. We agree with the authors, who conclude that the overall
higher Vp during tamponade is likely due to a catecholamine-
driven increase in LV relaxation. The fact that Vp decreased after
pericardiocentesis, when venous return to the LV should increase,
further supports that Vp is a preload-insensitive index.
Mario J. Garcia, MD, FACC
The Cleveland Clinic Foundation
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Apolipoprotein E Genotype
and Coronary Heart Disease
We have read with interest the article by Frikke-Schmidt et al. (1),
which concludes that male carriers of the Apo E epsilon43 and
epsilon44 genotypes are particularly susceptible to ischemic heart
disease.
We studied 220 men younger than 50 years of age (mean age
43 6 5 years; range 26 to 50 years) and diagnosed with coronary
artery disease (CAD). The polymorphisms of the apolipoprotein E
(Apo E) were determined and compared to a control group of 200
healthy individuals matched with patients for age and ethnicity and
residents in the same region (Asturias, northern Spain). We
analyzed the principal cardiovascular risk factors, and during
hospitalization and after fasting for 12 h a lipid profile study was
carried out.
The Apo E genotype frequencies are summarized in Table 1. In
our population, the Apo E gene and genotype frequencies were
similar between patients and controls. Also, Apo E gene and
genotype frequencies did not differ between patients with or
without diabetes, or with or without hypertension. In addition,
average biochemical values did not differ between the genotypes of
each of the four polymorphisms.
Compared to other Caucasian populations, we found a lower
frequency of the Apo Ee4 allele. These data are in agreement with
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previous reports that showed the lowest frequency for the e4 allele
in Southern European populations (2–6). The low frequency of
the e4-frequency allele among Mediterraneans has been linked
with a decreased risk of CAD in these populations, compared to
Northern Europeans, who have the highest e4-frequency and the
highest rate for CAD in Europe.
In accord with this, we did not find a significant difference for
the Apo E gene and genotype frequencies between patients and
controls, suggesting that the e4 allele is not a strong risk factor for
early CAD in our population. The role of Apo E genotypes in the
risk of CAD has been analyzed previously (7,8).
For the e4-allele, a significantly increased frequency in patients
compared to healthy controls has been described in some but not
all studies. These discrepancies could be partly attributed to the
fact that these studies analyzed different populations worldwide,
and the e4-allele could be a risk factor in association with other
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REPLY
We appreciate the comments of Batalla et al. concerning our paper
on premature coronary artery disease (CAD). The authors share
with us their data on young adults admitted with acute coronary
syndrome. They also provide follow-up information in the sub-
group with normal cholesterol compared to those with abnormal
cholesterol levels as defined by the ratio of total cholesterol to high
density lipoprotein levels. There are some similarities between
their data and ours; however, major differences exist. Similar
features include the fact that both studies evaluated young adults
age 50 years or younger. Second, both populations were high risk,
with high rates of categorical risk factors. For instance, the rate of
smoking was 73% in their study compared to 75% in our group.
The rate of hypertension was 36% and diabetes mellitus was 9% in
Batalla et al., which is similar to the 39% and 12% in our study for
those two conditions, respectively.
Hypercholesterolemia was 77% in their report. The rate of
hypercholesterolemia was 46% in our report, but the two studies
used different definitions. A comparison between the two studies is
limited by major differences in methodology and incomplete data
provided by the authors. First, their report involves exclusively
male subjects, whereas as many as 30% of our population were
young women. Second, their analysis was done by comparing two
groups based on cholesterol levels. We, in contrast, compared two
groups based on irrefutable evidence of significant CAD. Further-
more, they do not specify the time period over which the data was
collected. For this reason we do not know the frequency of
admissions for premature CAD. Next, what percent does this
represent for admissions of acute coronary syndrome?
We commend the authors for providing follow-up information
on outcomes. In their report, after 32 months’ follow-up there
were no differences in outcome between those with abnormal
compared to normal cholesterol. They conclude that the absence of
differences in outcomes represents a lack of benefit of low choles-
terol in young adults with high rates of smoking. This interpreta-
tion is similar to an earlier report by Jee et al. (1) in subjects
without previous CAD. The suggestion that low cholesterol does
not confer a benefit for secondary prevention in young adults has
important clinical implications. There are, however, other possible
explanations. This was an observational study that did not consider
the effect of treatment. It is possible that the lack of outcome
differences may be attributable to some treatment benefit in the
group with high cholesterol who were treated according to current
guidelines. This actually proves the merit of guidelines for second-
ary prevention.
Finally, a secondary explanation concerns the small sample size.
With a small sample size in each group it is possible that one
would need a much longer duration of follow-up to appreciate
differences. We do agree that, in young adults with multiple
cardiovascular risk factors, the best strategy to reduce recurrent
events in the short term should be based on managing all





(n 5 200) p
e33 174 (79%) 151 (75%) NS
e34 32 (15%) 28 (15%) NS
e44 4 (2%) 2 (1%) NS
e23 9 (4%) 18 (9%) NS
e24 1 1 NS
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